Spanish fair surpasses expectations


Granada – “We’ve broken all records.” This was Jose Luis Jarcano’s (Genoma Espana) conclusion after the end of the 4th BioSpain in Granada, Spain’s 3rd largest bio­tech cluster. “BioSpain 2008 has attracted more exhibitors, professionals and international delegates than any of its predecessors,” said Jose Maria Fernendez, President of the co-organising Spanish Association of Bioenterprises (ASEBIO). “The numbers demonstrate that the sector is in good health.”
The three-day event surpassed the BioSpain 2006 held in Madrid. Many of the 162 exhibitors spoke of a “tremendous leap in quality”, because practically the entire domestic sector took part. A high-ranking scientific congress entitled “Biotech 2008”, organised by Spanish biotech society SEBIOT, spanned a wide spectrum of issues: from bio­chemical engineering to agri-food, industrial biotech to microbial genomics, biocatalysis to bioinformatics. A partnerning forum organised by the EBD group counted 1,000 face-to-face meetings. In addition, 5 out of the 28 biotechs presenting to international investors were rewarded at the end of BioSpain’s finance forum: SpinX (Switzerland), CelleriX (Spain), Alfama (Portugal), Amsterdam Molecular Therapies (Netherlands, and Sinali Seafields (US). A further highlight was a plenary lecture by Steven Burrill, head of an international investor group, who underlined that biotech as a enabling technology will penetrate medicine and many areas of daily life by 2020.
“Biotechnology in Spain is currently growing at a rate of more than 25% per year” in terms of sales and exports, employment and attraction of investments, said Science and Innovation Minister Cristina Garmendia at BioSpain’s inauguration. “This is much higher than average rates in the US and the rest of Europe.” Garmendia, a former president at Genetrix, also underlined the importance of internationalisation, which she said would be paid back in exports, alliances and foreign investment.



Madrid – Nowhere in the world, is the concentration of GM-sceptics higher than it is in Europe, but their reign is not supreme. On the south-western tip of the continent, Spain stands out for its “science-based agricultural...



Seville – Genetrix S.L. and the Botín Foundation will channel a 6m over the next three years into the new company Axontherapix SL. The public-private partnership will seek to develop an effective therapy for Parkinson’s Disease....



Pamplona – With a record-setting Biospain this year, the Spanish biotech industry has underpinned its role as a premier player in the sector in southern Europe. More than 1,400 business representatives flocked to Pamplona, where...



Bilbao – Spanish Progenika Biopharma S.A has gained the green light for sale of its LPLchip in Europe. The DNA chip, which has achieved the CE mark, detects approximately 120 mutations in the lipoprotein lipase (LPL) gene and...



Madrid – Responding to the current debate surrounding the reactome array investigation, Manuel Ferrer from the Institute of Catalysis and Petrochemistry in Madrid told EuroBiotechNews his team would “clarify all the scientific...



Madrid – When Chinese Premier Wen Jiabao met his Spanish colleague Jose Luis Rodriguez Zapatero on August 31st, he talked about the Mediterranean country’s role as an important economic partner for China, and said cooperation...



Madrid/Braunschweig - Spanish and German scientists who last year reported a groundbreaking technology that is able to identify the whole set of biochemical reactions in bacteria or cells, together with the enzymes involved, have...



Barcelona – While the cash-strapped Spanish government is being stripped of its AAA grade investment rating, one of the giants of the country’s life science industry is on a spending spree. Grifols, a producer of plasma protein...



Barcelona/Nantes – Biomarker-specialist TcLand Expression in Nantes has found an ally in the Vall d’Hebron University Hospital Research Institute (HVIR) in Barcelona. The French company and the Spanish clinic will work together...

Displaying results 21 to 30 out of 181

< Previous 21-30 Next >

© 2007-2015 BIOCOM


LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Product of the week



All Events


Frankfurt am Main (DE)


Stock list

All quotes


  • BASILEA133.60 CHF4.70%
  • WILEX4.20 EUR3.45%


  • MEDIGENE8.58 EUR-4.88%
  • PAION2.51 EUR-4.56%
  • CYTOS0.63 CHF-3.08%


  • 4SC4.65 EUR257.7%
  • SYNGENTA422.00 CHF28.3%
  • SARTORIUS169.65 EUR18.6%


  • CYTOS0.63 CHF-37.6%
  • MEDIGENE8.58 EUR-33.2%
  • CO.DON2.89 EUR-8.3%


  • WILEX4.20 EUR418.5%
  • FORMYCON27.70 EUR316.5%
  • 4SC4.65 EUR315.2%


  • MOLOGEN4.92 EUR-53.7%
  • BIOFRONTERA2.30 EUR-28.6%
  • PAION2.51 EUR-22.8%

No liability assumed, Date: 25.05.2015

Current issue

All issues